REPRONEX(menotropins for injection, USP)

Company
Ferring Pharmaceuticals

Approval Status
Approved February 1997

Treatment for
Treatment for infertility

Areas
Cardiovascular / Cardiology , Diabetes / Endocrinology

REPRONEX, the generic equivalent of Pergonal, has been approved for the treatment of infertility. REPRONEX is a human menopausal gonadotropin (hMG), administered by intramuscular injection. Ferring has received FDA clearance to market REPRONEX for sequential use with human chorionic gonadotripin (hCG) in induction of ovulation and pregnancy in anovulatory infertile patients, and for stimulating the development of multiple follicles in ovulatory patients participating in an in vitro fertilization (IVF) program.

REPRONEX is also indicated for concomitant use with hCG for the stimulation of spermatogenesis in men who have primary or secondary hypogonadotropic hypogonadism.

REPRONEX(menotropins for injection, USP) Drug Information

The REPRONEX(menotropins for injection, USP) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top